GB9208428D0 - Synthetic polypeptides - Google Patents

Synthetic polypeptides

Info

Publication number
GB9208428D0
GB9208428D0 GB929208428A GB9208428A GB9208428D0 GB 9208428 D0 GB9208428 D0 GB 9208428D0 GB 929208428 A GB929208428 A GB 929208428A GB 9208428 A GB9208428 A GB 9208428A GB 9208428 D0 GB9208428 D0 GB 9208428D0
Authority
GB
United Kingdom
Prior art keywords
synthetic polypeptides
polypeptides
synthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929208428A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Protherics Medicines Development Ltd
Original Assignee
Proteus Molecular Design Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteus Molecular Design Ltd filed Critical Proteus Molecular Design Ltd
Priority to GB929208428A priority Critical patent/GB9208428D0/en
Publication of GB9208428D0 publication Critical patent/GB9208428D0/en
Priority to ZA932648A priority patent/ZA932648B/en
Priority to PCT/GB1993/000808 priority patent/WO1993021218A1/en
Priority to JP5518145A priority patent/JPH07505878A/en
Priority to AU39604/93A priority patent/AU3960493A/en
Priority to CN93105907A priority patent/CN1082053A/en
Priority to CA002118033A priority patent/CA2118033A1/en
Priority to EP93909057A priority patent/EP0636145A1/en
Priority to KR1019940703649A priority patent/KR950700933A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
GB929208428A 1992-04-16 1992-04-16 Synthetic polypeptides Pending GB9208428D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB929208428A GB9208428D0 (en) 1992-04-16 1992-04-16 Synthetic polypeptides
ZA932648A ZA932648B (en) 1992-04-16 1993-04-15 Sythetic polypeptides
PCT/GB1993/000808 WO1993021218A1 (en) 1992-04-16 1993-04-16 Synthetic polypeptides derived from the hiv envelope glycoprotein
JP5518145A JPH07505878A (en) 1992-04-16 1993-04-16 Synthetic polypeptide derived from HIV envelope glycoprotein
AU39604/93A AU3960493A (en) 1992-04-16 1993-04-16 Synthetic polypeptides derived from the HIV envelope glycoprotein
CN93105907A CN1082053A (en) 1992-04-16 1993-04-16 Synthetic polypeptide
CA002118033A CA2118033A1 (en) 1992-04-16 1993-04-16 Synthetic polypeptides derived from the hiv envelope gylcoprotein
EP93909057A EP0636145A1 (en) 1992-04-16 1993-04-16 Synthetic polypeptides derived from the hiv envelope glycoprotein
KR1019940703649A KR950700933A (en) 1992-04-16 1994-10-14 Synthetic polypeptides derived from the HIV envelope glycoprotein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929208428A GB9208428D0 (en) 1992-04-16 1992-04-16 Synthetic polypeptides

Publications (1)

Publication Number Publication Date
GB9208428D0 true GB9208428D0 (en) 1992-06-03

Family

ID=10714175

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929208428A Pending GB9208428D0 (en) 1992-04-16 1992-04-16 Synthetic polypeptides

Country Status (9)

Country Link
EP (1) EP0636145A1 (en)
JP (1) JPH07505878A (en)
KR (1) KR950700933A (en)
CN (1) CN1082053A (en)
AU (1) AU3960493A (en)
CA (1) CA2118033A1 (en)
GB (1) GB9208428D0 (en)
WO (1) WO1993021218A1 (en)
ZA (1) ZA932648B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
US5128319A (en) 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
AU667578B2 (en) 1992-08-27 1996-03-28 Deakin Research Limited Retro-, inverso-, and retro-inverso synthetic peptide analogues
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
AUPM411994A0 (en) * 1994-02-25 1994-03-24 Deakin Research Limited Epitopes
FR2717081B1 (en) * 1994-03-14 1996-06-21 Centre Nat Rech Scient Retropeptides, antibodies to the latter, and their uses for vaccination and in vitro diagnosis.
US5705522A (en) * 1995-09-15 1998-01-06 Compagnie De Developpement Aguettant S.A. Compounds having anti-inflammatory and anti-viral activity, compositions of these, alone and in combination with reverse transcriptase inhibitors
CN100366633C (en) * 2006-04-18 2008-02-06 河北师范大学 Antiviral polypeptide from Zongdian Tuanwa frog and its application in pharmacy
JP2008173077A (en) * 2007-01-22 2008-07-31 National Institute Of Advanced Industrial & Technology Monitor protein for analyzing expression of membrane protein

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714802D0 (en) * 1987-06-24 1987-07-29 Proteus Biotech Ltd Synthetic polypeptides
EP0330359A3 (en) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Composition useful in the diagnosis and treating of hiv-1 infection
WO1989010416A1 (en) * 1988-04-20 1989-11-02 Trustees Of The University Of Pennsylvania PROTECTIVE PEPTIDES DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUS-1 gp160
CA2003383A1 (en) * 1988-11-23 1990-05-23 Sushil G. Devare Synthetic dna derived recombinant hiv antigens
GB9005829D0 (en) * 1990-03-15 1990-05-09 Proteus Biotech Ltd Synthetic polypeptides

Also Published As

Publication number Publication date
JPH07505878A (en) 1995-06-29
ZA932648B (en) 1994-10-15
EP0636145A1 (en) 1995-02-01
KR950700933A (en) 1995-02-20
CN1082053A (en) 1994-02-16
AU3960493A (en) 1993-11-18
CA2118033A1 (en) 1993-10-28
WO1993021218A1 (en) 1993-10-28

Similar Documents

Publication Publication Date Title
GB2269176B (en) Peptides
ZA911886B (en) Synthetic polypeptides
GB9208428D0 (en) Synthetic polypeptides
ZW9093A1 (en) Synthetic polypeptides
GB9324013D0 (en) Polypeptides
GB9311273D0 (en) Synthetic polypeptides
GB9219710D0 (en) Synthetic polypeptides
GB9218163D0 (en) Synthetic polypeptides
GB9214663D0 (en) Synthetic polypeptides
GB9311296D0 (en) Synthetic polypeptides
ZA929392B (en) Synthetic polypeptides
GB9106674D0 (en) Synthetic polypeptides
GB9105871D0 (en) Synthetic peptides
GB9213437D0 (en) Polypeptides
GB9218056D0 (en) Polypeptides
GB9125931D0 (en) Polypeptides
GB9117985D0 (en) Polypeptides
GB9102799D0 (en) Polypeptides
GB9416018D0 (en) Synthetic polypeptides
GB9324350D0 (en) Polypeptides
IE892648L (en) Synthetic polypeptides
GB9009623D0 (en) Polypeptides
GB9016215D0 (en) Polypeptides
ZM1991A1 (en) Polypeptides
GB8804655D0 (en) Synthetic polypeptides